Seda Packaging Group: Revolutionary New Paper Lid Delivers Integrated Sustainable Drinking Solutions
23.1.2025 06:00:00 CET | Business Wire | Press release
Seda International Packaging Group’s versatile new EcoFit Lids offer complete plastic reduction and the lowest energy and water consumption manufacturing process
In a radical development significantly advancing sustainability, Seda International has proudly introduced its innovative EcoFit Lid on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122180654/en/

The compostable Double Wall cold cups with EcoFit lids for a superior beverage experience (Photo: Luciano Romano)
The EcoFit Lid has been thoughtfully designed to completely replace traditional plastic lids with a leak- and spill-resistant solution that delivers a superior drinking experience for hot and cold beverages alike. Enhancing safety, an audible snap confirms it has engaged fully with the cup rim for a secure, tight fit that’s better both in-store and during delivery.
Conceived following Seda’s rigorous ecodesign principles, the EcoFit Lid is also an exceptionally flexible and versatile solution. Available in Flat & Domed options, each offers a choice of triangular or oval sip hole with either a C-cut, cross-cut or Push & Lift action to provide a fully-tailored consumer experience and brand personality.
Crafted from 100% certified renewable fibres, the EcoFit lid can be combined with Seda’s cutting-edge printing technology to offer exceptional branding opportunities. It has the lowest environmental impact of any fibre lid in terms of CO₂ Emissions and Water Consumption for the entire supply chain, from cradle to grave.
A Life Cycle Assessment (LCA) conducted using EU data has conclusively demonstrated the EcoFit lid's superiority over other lid options, including moulded fibre and plastic PS and PP lids. This was confirmed by a recent Seda gate-to-gate screening showing EcoFit’s substantial environmental benefits, including significantly lower production cycle water and energy consumption as well as carbon emissions than even moulded fibre lids.
Fully recyclable in the paper stream and also available in a compostable version to meet all needs and usage scenarios, the EcoFit Lidis set to massively reduce the depletion of fossil resources caused by current plastic lids, saving 400 tons of plastic for every 100 million lids.
Brands can consequently make measurable progress towards reducing their environmental impact by choosing EcoFit Lids to support their sustainability goals and contribute to a lower carbon footprint in the packaging supply chain.
Equally important, the EcoFit Lid is not an isolated solution but has been expressly designed to form an integrated, fully sustainable package with Seda’s Double Wall cups. An original Seda innovation developed for hot beverages and patented in the early 2000s, the Double Wall Cup has set the industry standard ever since.
Seda’s more recently introduced Double Wall Cold Cups are made from the same sustainable, printable paperboard and have likewise been conceived to deliver a superior drinking experience. Their unique, patented air gap design ensures beverages stay cold for longer, while greatly reducing condensation and sweating to provide a much more enjoyable tactile sensation compared with single wall cold cups made of paper or plastic. Consumers appreciate how their drinks remain cool and satisfying without worrying about condensation or slippery cups, making each sip as refreshing as the first.
These cups and lids have been specifically designed to meet the growing demands of evolving legislation across Europe that increasingly favours sustainable packaging solutions. Seda’s new offering thus provides a transformative solution for businesses that need to rapidly adapt to new environmental regulations.
“Our new EcoFit Lids and compostable Double Wall cold cups underscore Seda Group’s dedication to continuous innovation and sustainability,” said Armando Mariano, Director of Innovation, R&D, Materials, and Sustainability at Seda Group. “These products were designed with the future in mind, addressing environmental concerns and evolving consumer demands. By significantly reducing water consumption and CO2 emissions, our EcoFit Lid sets a new benchmark in sustainable beverage packaging. We are proud to offer solutions that not only comply with stringent regulations but also enhance the consumer experience while helping brands make meaningful progress towards their sustainability goals.”
As European consumers increasingly demand more sustainable products, Seda continues to lead the market with the most innovative and sustainable packaging solutions, consistently delivering top-quality products that meet customer expectations with outstanding service.
Leading coffee, restaurant, and convenience store brands worldwide are already adopting these innovations to meet their sustainability objectives.
Seda International Packaging Group is a leading provider of sustainable food and food service packaging solutions. Headquartered in Naples, Italy, Seda operates manufacturing platforms across Italy, Germany, Portugal, the UK and North America.
Discover more about Seda at www.sedagroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122180654/en/


Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom